The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment.

MLA

Yeh, Ming‐Lun, et al. “The Prognostic Factors between Different Viral Etiologies among Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Treatment.” Kaohsiung Journal of Medical Sciences, vol. 35, no. 10, Oct. 2019, pp. 624–32. EBSCOhost, https://doi.org/10.1002/kjm2.12105.

APA

Yeh, M., Huang, C., Huang, C., Hsieh, M., Hou, N., Lin, I., Liang, P., Tsai, Y., Hsieh, M., Lin, Z., Chen, S., Dai, C., Huang, J., Yu, M., & Chuang, W. (2019). The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment. Kaohsiung Journal of Medical Sciences, 35(10), 624–632. https://doi.org/10.1002/kjm2.12105

Chicago

Yeh, Ming‐Lun, Chung‐Feng Huang, Ching‐I Huang, Ming‐Yen Hsieh, Nei‐Jen Hou, I‐Hung Lin, Po‐Cheng Liang, et al. 2019. “The Prognostic Factors between Different Viral Etiologies among Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Treatment.” Kaohsiung Journal of Medical Sciences 35 (10): 624–32. doi:10.1002/kjm2.12105.